What this study is
The purpose of this study is to assess the awareness of eligibility of lung cancer screening in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to understand the barriers to screening using qualitative interviews.
What's being tested
- Lung Cancer Screening Education
Intervention · BEHAVIORAL
Tailored lung cancer screening education will consist of an annual, in-person 60 minute visit of lung cancer screening education in the participant's native language with material in layman's terms about the importance of lung cancer screening, tobacco cessation, and the risk of developing a second primary lung cancer.
- Semi-Structured Interview
Intervention · BEHAVIORAL
Participants will undergo an annual, in-person or virtual, semi-structured interviews to understand barriers and perception towards screening and cultural competencies to increase adherence to lung cancer screening. The interviews will last approximately 30 minutes at each visit.
- Standard of Care Lung Cancer Screening Program
Intervention · BEHAVIORAL
Participants will receive standard of care referral to the University of Miami's Lung Cancer Screening Program. The standard education includes a one-time, in-person or virtual 60-minute visit with the Advanced Practice Registered Nurse (APRN) to review educational material about lung cancer screening and tobacco cessation guidelines, and to discuss the risks versus benefits of undergoing screening.
Study details
- Official title
- GUIAR: PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
- Sponsor
- University of Miami
- Conditions
- Head and Neck Cancer
- Enrolling
- 44 people
- Starts
- 2024-04-11
- Est. completion
- 2029-04-30
- Design
- Single-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Participants must be able to understand, and sign informed consent form.
- Age ≥ 18 years.
- Participants must self-identify as Hispanic/LatinX.
- Individuals must be head and neck cancer survivors (treated locally with surgery, radiation alone, or definitive chemoradiation ≥ 5 years earlier and have no signs/symptoms to suggest recurrence of disease).
- Subjects that meet lung cancer (LC) screening eligibility according to United States Preventive Services Task Force (USPSTF21) and/or National Comprehensive Cancer Network (NCCN). For patients with a history of head and neck cancers, the NCCN recommends annual screening with low dose computerized tomography (LDCT) in those who have had a history of 20 pack years of smoking or more. USPSTF21 LC screening eligibility includes adults ages 50-80 that are current smoker or former smokers that quit within 15 years and have a 20 pack-year history or more of smoking.
You can't join if
- Individuals with pre-established diagnosis of lung cancer.
- Participants with current diagnosis of any active malignancy.
- Subjects that had undergone lung imaging within previous 3 years.
- Pregnant or nursing mothers.
- Individuals that received head and neck related treatment less than 5 years before screening.
- Individuals with < 20 pack year history of smoking.
- Subjects with previous history of distant metastatic head and neck cancer.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Miami
Miami, Florida, United States
- Coral Olazagasti, MD · Contact305-243-4334cxo379@med.miami.edu
- Coral Olazagasti, MD · Principal investigator
Recruiting
Study team
Sponsor
University of Miami
Study ID 20220746
Principal investigator
Coral Olazagasti, MD
University of Miami
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.